Authors:
Coward, K
Jowett, A
Plumpton, C
Powell, A
Birch, R
Tate, S
Bountra, C
Anand, P
Citation: K. Coward et al., Sodium channel beta 1 and beta 2 subunits parallel SNS/PN3 alpha-subunit changes in injured human sensory neurons, NEUROREPORT, 12(3), 2001, pp. 483-488
Authors:
Coward, K
Aitken, A
Powell, A
Plumpton, C
Birch, R
Tate, S
Bountra, C
Anand, P
Citation: K. Coward et al., Plasticity of TTX-sensitive sodium channels PNI and brain III in injured human nerves, NEUROREPORT, 12(3), 2001, pp. 495-500
Authors:
Coward, K
Mosahebi, A
Plumpton, C
Facer, P
Birch, R
Tate, S
Bountra, C
Terenghi, G
Anand, P
Citation: K. Coward et al., Immunolocalisation of sodium channel NaG in the intact and injured human peripheral nervous system, J ANAT, 198, 2001, pp. 175-180
Citation: Cm. Kozlowski et al., The effect of fentanyl, DNQX and MK-801 on dorsal horn neurones responsiveto colorectal distension in the anaesthetized rat, NEUROG MOT, 12(3), 2000, pp. 239-247
Authors:
Kozlowski, CM
Green, A
Grundy, D
Boissonade, FM
Bountra, C
Citation: Cm. Kozlowski et al., The 5-HT3 receptor antagonist alosetron inhibits the colorectal distentioninduced depressor response and spinal c-fos expression in the anaesthetised rat, GUT, 46(4), 2000, pp. 474-480
Authors:
Clayton, NM
Sargent, R
Butler, A
Gale, J
Maxwell, MP
Hunt, AAE
Barrett, VJ
Cambridge, D
Bountra, C
Humphrey, PPA
Citation: Nm. Clayton et al., The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat, NEUROG MOT, 11(3), 1999, pp. 207-217
Authors:
Humphrey, PPA
Bountra, C
Clayton, N
Kozlowski, K
Citation: Ppa. Humphrey et al., Review article: the therapeutic potential of 5-HT3 receptor antagonists inthe treatment of irritable bowel syndrome, ALIM PHARM, 13, 1999, pp. 31-38
Authors:
Munglani, R
Hudspith, MJ
Fleming, B
Harrison, S
Smith, G
Bountra, C
Elliot, PJ
Birch, PJ
Hunt, SP
Citation: R. Munglani et al., Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain, BRAIN RES, 822(1-2), 1999, pp. 210-219
Authors:
Hudspith, MJ
Harrisson, S
Smith, G
Bountra, C
Elliot, PJ
Birch, PJ
Hunt, SP
Munglani, R
Citation: Mj. Hudspith et al., Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain, BRAIN RES, 822(1-2), 1999, pp. 220-227